Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. May 14, 2014; 20(18): 5171-5176
Published online May 14, 2014. doi: 10.3748/wjg.v20.i18.5171
Published online May 14, 2014. doi: 10.3748/wjg.v20.i18.5171
Table 1 Characteristics of commonly used pharmacological agents used during endoscopy
| Agent | Onset of action (min) | Duration of action | Half life | Metabolism |
| Midazolam | 1.0-2.5 | 2-6 h | 1.8-6.4 h | Hepatic and intestinal |
| Fentanyl | < 1.5 | 1-2 h | 2-7 h | Hepatic |
| Meperidine | 5 | 2-4 h | 2-7 h | Hepatic |
| Propofol | > 1 | 3-10 min | Triphasic: 2.2 min, 20 min, 8 h | Hepatic |
Table 2 American Society of Gastrointestinal Endoscopy training guidelines for nonanesthesiologist-administered propofol for gastrointestinal endoscopy
| Didactic training |
| Pharmacological overview of propofol |
| Review of continuum of sedation |
| Patient assessment specific to propofol |
| Examination |
| Airway workshop |
| Training to recognize and manage respiratory complications |
| Airway assessment |
| Restore airway patency with manual, oral or nasopharyngeal techniques |
| Bag-mask ventilation |
| Basic and advanced cardiac life support |
| Review of physiologic monitoring techniques (capnography) |
| Simulation training |
| Clinical simulators with trained instructors |
| Preceptorship |
| Adopt and institute a propofol sedation program within endoscopy unit |
| Formulate set of policies and procedures pertaining to NAAP |
| Train all relevant members of staff |
| Institutional approval |
| Performance measures designed to assess patient safety and satisfaction |
- Citation: Cheriyan DG, Byrne MF. Propofol use in endoscopic retrograde cholangiopancreatography and endoscopic ultrasound. World J Gastroenterol 2014; 20(18): 5171-5176
- URL: https://www.wjgnet.com/1007-9327/full/v20/i18/5171.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i18.5171
